Mustafa Karaca - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mustafa Karaca

Showing results (81-90 of 83) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 83 results.

Current Oncology (Toronto, Ont.)|September 27, 2024

Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?Birol Ocak, Ahmet Bilgehan Sahin, Ismail Ertürk, et al.

Scientific Reports|January 25, 2025

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group studyNargiz Majidova, Hacı Arak, Faruk Recep Ozalp, et al.

Journal of Cancer Research and Clinical Oncology|April 17, 2023

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) studyAhmet Bilici, Sinan Koca, Mustafa Karaagac, et al.

Pageof 9

Search research articles

Showing results (81-90 of 83) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 83 results.

Current Oncology (Toronto, Ont.)|September 27, 2024

Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?Birol Ocak, Ahmet Bilgehan Sahin, Ismail Ertürk, et al.

Scientific Reports|January 25, 2025

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group studyNargiz Majidova, Hacı Arak, Faruk Recep Ozalp, et al.

Journal of Cancer Research and Clinical Oncology|April 17, 2023

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) studyAhmet Bilici, Sinan Koca, Mustafa Karaagac, et al.

Pageof 9